• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ASCO、NCCN、MASCC/ESMO:成人患者化疗所致恶心呕吐治疗止吐指南的比较。

ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients.

机构信息

Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.

Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.

出版信息

Support Care Cancer. 2019 Jan;27(1):87-95. doi: 10.1007/s00520-018-4464-y. Epub 2018 Oct 3.

DOI:10.1007/s00520-018-4464-y
PMID:30284039
Abstract

Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with a variety of early- and end-stage malignancies. In light of recent changes in the optimal management of CINV, we undertook this narrative review to compare the latest guidelines published by ASCO (2017), NCCN (2018), and MASCC/ESMO (2016). The processes undertaken by each organization to evaluate existing literature were also described. Although ASCO, NCCN, and MASCC/ESMO guidelines for the treatment and prevention of CINV share many fundamental similarities, literature surrounding low and minimal emetic risk regimens is lacking. Data regarding the use of complementary alternative medicine for CINV is particularly scarce and in need of further investigation.

摘要

化疗引起的恶心和呕吐(CINV)是一种常见的毒性反应,可能会降低各种早期和晚期恶性肿瘤患者的生活质量。鉴于 CINV 的最佳管理方法最近发生了变化,我们进行了这次叙述性综述,以比较 ASCO(2017 年)、NCCN(2018 年)和 MASCC/ESMO(2016 年)发布的最新指南。还描述了每个组织评估现有文献所采用的过程。尽管 ASCO、NCCN 和 MASCC/ESMO 治疗和预防 CINV 的指南有许多基本相似之处,但针对低和最小致吐风险方案的文献却很少。关于 CINV 中使用补充和替代医学的数据尤其稀缺,需要进一步研究。

相似文献

1
ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients.ASCO、NCCN、MASCC/ESMO:成人患者化疗所致恶心呕吐治疗止吐指南的比较。
Support Care Cancer. 2019 Jan;27(1):87-95. doi: 10.1007/s00520-018-4464-y. Epub 2018 Oct 3.
2
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.2020 年 ASCO、2023 年 NCCN、2023 年 MASCC/ESMO 和 2019 年 CCO:癌症患者化疗所致恶心呕吐治疗中止吐指南的比较。
Support Care Cancer. 2024 Apr 10;32(5):280. doi: 10.1007/s00520-024-08462-x.
3
Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.放射性恶心和呕吐:MASCC/ESMO、ASCO 和 NCCN 止吐指南比较。
Support Care Cancer. 2019 Mar;27(3):783-791. doi: 10.1007/s00520-018-4586-2. Epub 2019 Jan 3.
4
International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.国际抗肿瘤药物所致恶心呕吐防治指南(CINV):内容与日常实践中的应用。
Eur J Pharmacol. 2014 Jan 5;722:197-202. doi: 10.1016/j.ejphar.2013.09.073. Epub 2013 Oct 21.
5
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.造血干细胞移植患者的止吐预防:意大利骨髓移植组(GITMO)移植项目的多中心调查。
Ann Hematol. 2020 Apr;99(4):867-875. doi: 10.1007/s00277-020-03945-3. Epub 2020 Feb 8.
6
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.2016年更新的MASCC/ESMO共识建议:控制低致吐或极低致吐风险化疗引起的恶心和呕吐
Support Care Cancer. 2017 Jan;25(1):297-301. doi: 10.1007/s00520-016-3391-z. Epub 2016 Aug 30.
7
[Emetogenic potential of antineoplastic agents based on clinical trials in Japan].基于日本临床试验的抗肿瘤药物致吐潜力
Gan To Kagaku Ryoho. 2015 Mar;42(3):335-41.
8
Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.遵循止吐指南对化疗引起的恶心和呕吐发生率及生活质量的影响。
Int J Clin Pharm. 2016 Dec;38(6):1464-1476. doi: 10.1007/s11096-016-0393-3. Epub 2016 Oct 28.
9
Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey.评价预防化疗引起的恶心和呕吐(CINV)的止吐实践:一项欧洲肿瘤护士调查的结果。
Support Care Cancer. 2019 Nov;27(11):4099-4106. doi: 10.1007/s00520-019-04697-1. Epub 2019 Feb 19.
10
Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.测试止吐指南的有效性:日本CINV研究组前瞻性登记研究结果
Int J Clin Oncol. 2015 Oct;20(5):855-65. doi: 10.1007/s10147-015-0786-7. Epub 2015 Feb 15.

引用本文的文献

1
Cannabinoids for the prevention of chemotherapy-induced nausea and vomiting in oncological therapy: a systematic review.大麻素类药物在肿瘤治疗中预防化疗引起的恶心和呕吐:一项系统评价
J Cancer Surviv. 2025 Aug 12. doi: 10.1007/s11764-025-01876-4.
2
GDF15 and history of pregnancy-induced nausea as predictors of treatment-induced nausea severity in women following surgery for early-stage breast cancer.生长分化因子15及妊娠剧吐史作为早期乳腺癌术后女性治疗引起的恶心严重程度的预测指标
Support Care Cancer. 2025 Jul 23;33(8):714. doi: 10.1007/s00520-025-09769-z.
3
Neurokinin-1 receptor antagonists in the current management of chemotherapy-induced nausea and vomiting.

本文引用的文献

1
Relationship among symptom clusters, quality of life, and treatment-specific optimism in patients with cancer.癌症患者症状群、生活质量与治疗特异性乐观的关系。
Support Care Cancer. 2018 Aug;26(8):2685-2693. doi: 10.1007/s00520-018-4102-8. Epub 2018 Feb 23.
2
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use.在一个医用大麻和娱乐用大麻均合法化的州,一家综合癌症中心的患者使用大麻的情况。
Cancer. 2017 Nov 15;123(22):4488-4497. doi: 10.1002/cncr.30879. Epub 2017 Sep 25.
3
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.
神经激肽-1受体拮抗剂在当前化疗引起的恶心和呕吐管理中的应用
Front Med. 2025 Jul 5. doi: 10.1007/s11684-025-1140-8.
4
Practical Management of Zolbetuximab Administration: The Project VYLOY Initiative.佐贝妥昔单抗给药的实际管理:VYLOY项目倡议
Cancers (Basel). 2025 Jun 15;17(12):1996. doi: 10.3390/cancers17121996.
5
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective.化疗引起的恶心和呕吐管理专家共识指南:印度视角
Cureus. 2025 May 13;17(5):e84070. doi: 10.7759/cureus.84070. eCollection 2025 May.
6
Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer.乳腺癌患者接受高度致吐性化疗时预防性使用地塞米松的省略情况。
Einstein (Sao Paulo). 2025 May 12;23:eAO1124. doi: 10.31744/einstein_journal/2025AO1124. eCollection 2025.
7
Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccess.世界卫生组织药物不良反应数据库(WHO-VigiAccess)中四种常见肝细胞癌靶向药物不良反应的特征分析
Sci Rep. 2025 May 9;15(1):16188. doi: 10.1038/s41598-025-00004-7.
8
Personalized Prophylactic Antiemetic Regimens for Control of Chemotherapy-Induced Nausea and Vomiting by Pharmacogenetic Analysis of Three Receptor Genes: , , .通过对三个受体基因进行药物遗传学分析制定个性化预防性止吐方案以控制化疗引起的恶心和呕吐: , , 。
JCO Precis Oncol. 2025 Apr;9:e2400858. doi: 10.1200/PO-24-00858. Epub 2025 Apr 18.
9
The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects.高脂饮食对盐酸昂丹司琼片在中国健康受试者体内药代动力学的影响。
Front Pharmacol. 2025 Mar 21;16:1512857. doi: 10.3389/fphar.2025.1512857. eCollection 2025.
10
Developing and assessing a vomiting-free ward workflow for gynecological patients receiving chemotherapy.为接受化疗的妇科患者制定并评估无呕吐病房工作流程。
Support Care Cancer. 2025 Apr 5;33(4):358. doi: 10.1007/s00520-025-09422-9.
止吐药:美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2017 Oct 1;35(28):3240-3261. doi: 10.1200/JCO.2017.74.4789. Epub 2017 Jul 31.
4
Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan.突破性化疗引起的恶心和呕吐:日本化疗所致恶心呕吐研究组全国性调查结果报告
Int J Clin Oncol. 2017 Apr;22(2):405-412. doi: 10.1007/s10147-016-1069-7. Epub 2016 Dec 1.
5
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.2016年MASCC和ESMO关于预防化疗和放疗引起的恶心呕吐以及晚期癌症患者恶心呕吐的指南更新。
Ann Oncol. 2016 Sep;27(suppl 5):v119-v133. doi: 10.1093/annonc/mdw270.
6
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.奥氮平用于预防化疗引起的恶心和呕吐。
N Engl J Med. 2016 Jul 14;375(2):134-42. doi: 10.1056/NEJMoa1515725.
7
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.神经激肽-1受体拮抗剂罗拉匹坦在预防接受卡铂化疗患者恶心和呕吐方面的疗效。
Cancer. 2016 Aug 1;122(15):2418-25. doi: 10.1002/cncr.30054. Epub 2016 May 13.
8
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.阿瑞匹坦预防中度致吐性化疗方案引起的化疗所致恶心和呕吐的疗效:一项针对接受紫杉醇和卡铂治疗的妇科癌症患者的多中心、安慰剂对照、双盲、随机研究。
Int J Clin Oncol. 2016 Jun;21(3):491-7. doi: 10.1007/s10147-015-0928-y. Epub 2015 Dec 10.
9
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.大麻素用于接受化疗的成年癌症患者的恶心和呕吐治疗。
Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD009464. doi: 10.1002/14651858.CD009464.pub2.
10
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial.单剂量福沙匹坦预防与中度致吐性化疗相关的化疗引起的恶心和呕吐:一项随机、双盲III期试验的结果
Ann Oncol. 2016 Jan;27(1):172-8. doi: 10.1093/annonc/mdv482. Epub 2015 Oct 8.